Highland Capital Management (Texas)’s Charles River Laboratories CRL Stock Holding History

Highland Capital Management (Texas)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$373K	Hold	2,632	–	–	0.02%	269
2019 Q1	$382K	Sell	2,632 -5,000	-66%	-$657K	0.02%	261
2018 Q4	$864K	Buy	7,632 +5,000	+190%	+$626K	0.07%	167
2018 Q3	$354K	Sell	2,632 -1,700	-39%	-$210K	0.02%	262
2018 Q2	$486K	Buy	4,332 +1,750	+68%	+$189K	0.03%	207
2018 Q1	$276K	Hold	2,582	–	–	0.01%	294
2017 Q4	$283K	Hold	2,582	–	–	0.01%	272
2017 Q3	$279K	Hold	2,582	–	–	0.01%	263
2017 Q2	$261K	Hold	2,582	–	–	0.01%	263
2017 Q1	$232K	Sell	2,582 -1,250	-33%	-$106K	0.01%	270
2016 Q4	$292K	Hold	3,832	–	–	0.01%	260
2016 Q3	$319K	Sell	3,832 -79,408	-95%	-$6.66M	0.01%	270
2016 Q2	$6.86M	Buy	+83,240	New	+$6.86M	0.28%	97

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Highland Capital Management (Texas)'s CRL Position: Q2 2019 in Review

Highland Capital Management (Texas) held its Charles River Laboratories (CRL) position steady in Q2 2019 at 2,632 shares worth $373K. The position accounts for 0.02% of the portfolio, ranked #269.

Highland Capital Management (Texas) first reported a position in CRL in Q2 2016 and has held it in 13 quarters since. The position peaked at $6.86M in Q2 2016. 405 funds tracked by Wall St. Rank hold CRL as of Q2 2019.

Highland Capital Management (Texas) held 2,632 shares of Charles River Laboratories worth $373K as of Q2 2019.
Highland Capital Management (Texas) left its Charles River Laboratories share count unchanged in Q2 2019.
Charles River Laboratories made up 0.02% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #269 holding.
Highland Capital Management (Texas) first reported a position in Charles River Laboratories in Q2 2016 and has held it in 13 quarters since.
Highland Capital Management (Texas)'s Charles River Laboratories position peaked at $6.86M in Q2 2016.
405 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.